We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

23 hedge funds and large institutions have $10.1M invested in Apollo Endosurgery, Inc. in 2014 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

35% more funds holding

Funds holding: 1723 (+6)

19% less capital invested

Capital invested by funds: $12.5M → $10.1M (-$2.33M)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $121K

Holders
23
Holders Change
+6
Holders Change %
+35.29%
% of All Funds
0.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
4
Reduced
5
Closed
2
Calls
Puts
$121K
Net Calls
-$121K
Net Calls Change
-$23K
Name Holding Trade Value Shares
Change
Change in
Stake
Franklin Resources
1
Franklin Resources
California
$4.41M
KCM
2
Kennedy Capital Management
Missouri
$1.8M +$15.2K +48 +0.8%
Allianz Asset Management
3
Allianz Asset Management
Germany
$929K -$99.7K -314 -9%
Bank of America
4
Bank of America
North Carolina
$570K +$317 +1 +0.1%
Vanguard Group
5
Vanguard Group
Pennsylvania
$539K
DCM
6
DAFNA Capital Management
California
$417K
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$376K -$19K -60 -5%
WMSA
8
Weiss Multi-Strategy Advisers
New York
$298K
California Public Employees Retirement System
9
California Public Employees Retirement System
California
$259K +$269K +848 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$182K -$635 -2 -0.3%
MCM
11
Marathon Capital Management
Maryland
$131K -$10.5K -33 -7%
Renaissance Technologies
12
Renaissance Technologies
New York
$92K +$95.6K +301 New
Northern Trust
13
Northern Trust
Illinois
$41K +$952 +3 +2%
First Manhattan
14
First Manhattan
New York
$37K
Morgan Stanley
15
Morgan Stanley
New York
$13K +$11.7K +37 +740%
BIM
16
BlackRock Investment Management
Delaware
$10K +$10.5K +33 New
Group One Trading
17
Group One Trading
Illinois
$8K -$7.3K -23 -48%
Creative Planning
18
Creative Planning
Kansas
$6K +$6.03K +19 New
HDIM
19
Hanson & Doremus Investment Management
Vermont
$5K +$5.08K +16 New
U
20
UBS
Switzerland
$3K +$3.49K +11 New
Manulife (Manufacturers Life Insurance)
21
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K
TRCT
22
Tower Research Capital (TRC)
New York
$1K +$1.59K +5 New
SAM
23
Sectoral Asset Management
Quebec, Canada
-$601K -1,642 Closed
SIM
24
Spark Investment Management
New York
-$51K -142 Closed
Deutsche Bank
25
Deutsche Bank
Germany
+$317 +1 New

APEN Hedge Fund Activity: Q2 2014 in Review

23 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q2 2014, worth a combined $10.1M — down 19% from $12.5M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new APEN positions and 2 closed out — a net gain of 6 holders — while 4 added to existing stakes and 5 trimmed.

The largest buyer was California Public Employees Retirement System, opening a new position worth an estimated $269K. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $601K sold.

  • 23 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q2 2014, up from 17 in Q1 2014.
  • Funds reported $10.1M of Apollo Endosurgery, Inc. stock for Q2 2014, down 19% quarter-over-quarter.
  • 8 funds opened new Apollo Endosurgery, Inc. positions in Q2 2014 and 2 closed out, a net change of +6 holders.
  • The largest Apollo Endosurgery, Inc. buyer in Q2 2014 was California Public Employees Retirement System, an estimated $269K added.
  • The largest Apollo Endosurgery, Inc. seller in Q2 2014 was Sectoral Asset Management, an estimated $601K sold.

Based on aggregated 13F filings for Q2 2014.